New Managing Director in FinVector


FinVector is pleased to announce the appointment of Giuseppe Carloni as Managing Director & Site Head of FinVector Oy with immediate effect.

“I feel delighted to work with this team. It will be challenging, but together we can make the difference and deliver a life-saving product to our patient”, comments Giuseppe.

Giuseppe has broad international experience in the Pharmaceutical Industry and Commercial Manufacturing, notably over 28 years with GlaxoSmithKline in a number of Site Head roles in Europe and the Americas. He brings expertise to further strengthen FinVector’s capabilities to be a world leader in Gene Therapy products development and manufacturing.

“We are very honored and pleased to have succeeded in recruiting Giuseppe Carloni to the position as Managing Director for FinVector. The company has grown vigorously during the last years, and we see tremendous growth potential ahead”, says Jean-Frédéric Paulsen, Chair from FinVector Board of Directors.

Former Managing Director Timo Ristola will continue as Deputy Managing Director for FinVector Oy.